Form 4: Lemaitre Vascular Director Boosts Stake with Stock Awards

Lemaitre Vascular Director Lawrence J. Jasinski acquired 533 restricted stock units and 3,431 stock options, increasing his beneficial ownership in the company.

Summary

• Lawrence J. Jasinski, a Director of Lemaitre Vascular Inc. (LMAT), reported changes in his beneficial ownership.
• He acquired 533 shares of Common Stock as a restricted stock unit (RSU) award on December 10, 2025, with a price of $0.
• These RSUs vest 33 1/3% on December 1, 2026, with the remainder vesting in equal annual installments over the subsequent two years.
• He also acquired 3,431 stock options (right to buy) on December 10, 2025, with an exercise price of $83.66 and a price of $0.
• These stock options are exercisable and vest over a three-year period, with 33 1/3% vesting on the first anniversary of December 1, 2025, and the balance in equal annual installments over the remaining two years.
• The options expire on December 10, 2030.
• Following these transactions, Mr. Jasinski beneficially owns 5,312 shares of Common Stock and 3,431 stock options.

Sentiment

Score: 7

Explanation: The acquisition of equity awards by a director is generally viewed positively as it aligns the director's interests with shareholders and can signal confidence in the company's future performance.

Positives

• Director Lawrence J. Jasinski increased his beneficial ownership in Lemaitre Vascular Inc. through the acquisition of 533 restricted stock units and 3,431 stock options.
• The acquisition of equity awards by a director can signal confidence in the company's future prospects and better align management interests with shareholders.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the vesting and expiration schedules of the equity awards.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• The filing details the grant of 533 restricted stock units and 3,431 stock options to Lawrence J. Jasinski, a Director of Lemaitre Vascular Inc. These equity awards are considered related party transactions between the company and its director.

Stakeholder Impact

• Shareholders: Increased director ownership may be seen as a positive signal, potentially aligning the director's long-term interests with those of shareholders.

Next Steps

• Vesting of 33 1/3% of restricted stock units on December 1, 2026, with the balance vesting in equal annual installments over the subsequent two years.
• Vesting of 33 1/3% of stock options on the first anniversary of December 1, 2025, with the balance vesting in equal annual installments over the subsequent two years.
• Expiration of stock options on December 10, 2030.

Key Dates

Keywords

Lemaitre Vascular Inc., LMAT, Insider Transaction, Form 4, Restricted Stock Unit, Stock Option, Director Ownership, Equity Award, Beneficial Ownership